ask="N/A"
ask_size="N/A"
average_daily_volume="334871"
bid="N/A"
bid_size="N/A"
book_value="0.34"
change="N/A"
change_from_200_day_moving_average="-0.01"
change_from_50_day_moving_average="0.04"
change_from_52_week_high="-3.44"
change_From_52_week_low="0.55"
change_in_percent="N/A"
close="1.66"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.49"
ebitda="-12.32M"
eps_estimate_current_year="-1.58"
eps_estimate_next_quarter="-0.36"
eps_estimate_next_year="-0.88"
ex_dividend_date="N/A"
float_shares="3683000"
high="N/A"
high_52_weeks="5.10"
last_trade_date="2/13/2017"
last_trade_price="1.66"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="N/A"
low_52_weeks="1.11"
market_capitalization="15.91M"
moving_average_200_day="1.67"
moving_average_50_day="1.62"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.00"
open="N/A"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-0.78%"
percent_change_from_50_day_moving_average="+2.73%"
percent_change_from_52_week_high="-67.45%"
percent_change_from_52_week_low="+49.55%"
previous_close="1.66"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.90"
price_per_sales="31.27"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="0.76"
stock_exchange="NCM"
symbol="EYEG"
volume="0"
weeks_range_52="1.11 - 5.10"
